Switching Methadone: A 10-Year Experience of 345 Patients in an Acute Palliative Care Unit

Pain Medicine

Volumn 13, Issue 3, 2012, Pages 399-404

  Mercadante, Sebastiano ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Cancer pain; Methadone; Opioids; Palliative treatment

Indexed keywords

BUPRENORPHINE; FENTANYL; HYDROMORPHONE; METHADONE; MORPHINE; NALOXONE; OPIATE; OXYCODONE;

ACUTE PALLIATIVE CARE UNIT; ADULT; AGED; ANALGESIA; ARTICLE; BRADYPNEA; CANCER PAIN; CANCER PATIENT; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; HEALTH CARE FACILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; RETROSPECTIVE STUDY;

EID: 84858620301     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2012.01334.x     Document Type: Article

References (22)

1. Cherny N, Ripamonti C, Pereira J, etal.; Expert Working Group of the European Association of Palliative Care Network. Strategies to manage the adverse effects of oral morphine: An evidence-based report. J Clin Oncol 2001;19:2542-54.
2. Mercadante S, Bruera E. Opioid switching: A systematic and critical review. Cancer Treat Rev 2006;32:304-15.
3. Weschules D, Bain K. A systematic review of opioid conversion ratios used with methadone for the treatment of pain. Pain Med 2008;9:595-612.
4. Quigley C. Opioid switching to improve pain relief and drug tolerability. Cochrane Database Syst Rev 2004;(3):CD004847.
5. Knotkova H, Fine P, Portenoy RK. Opioid rotation: The science and the limitations of the equianalgesic dose table. J Pain Symptom Manage 2009;38:426-39.
6. Slatkin N. Opioid switching and rotation in primary care: Implementation and clinical utility. Curr Med Res Opin 2009;25:2133-59.
7. Mercadante S, Casuccio A, Calderone L. Rapid switching from morphine to methadone in cancer patients with poor response to morphine. J Clin Oncol 1999;17:3307-12.
8. Mercadante S, Villari P, Ferrera P. A model of acute symptom control unit: Pain Relief and Palliative Care Unit of La Maddalena Cancer Center. Support Care Cancer 2003;11:114-9.
9. Mercadante S, Intravaia G, Villari P, etal. Clinical and financial analysis of an acute palliative care unit in an oncological department. Palliat Med 2008;22:760-7.
10. Mercadante S, Ferrera P, Villari P, etal. Frequency, indications, outcome, and predictive factors of opioid switching in an acute palliative care unit. J Pain Symptom Manage 2009;37:632-41.
11. Gonzalez-Barboteo J, Porta-Sales J, Sanchez D, Tuca A, Gomez-Batiste X. Conversion from parenteral to oral methadone. J Pain Palliat Care Pharmacother 2008;22:200-5.
12. Mercadante S, Ferrera P, Arcuri E. The use of fentanyl buccal tablets as breakthrough medication in patients receiving chronic methadone therapy: An open label preliminary study. Support Care Cancer 2011;19:435-8.
13. Bruera E, Pereira J, Watanabe S, etal. Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine. Cancer 1996;78:852-7.
14. Lawlor P, Turner K, Hanson J, Bruera E. Dose ratio between morphine and methadone in patients with cancer pain: A retrospective study. Cancer 1998;82:1167-73.
15. Ripamonti C, Groff L, Brunelli C, etal. Switching from morphine to oral methadone in treating cancer pain: What is the equianalgesic dose ratio? J Clin Oncol 1998;16:3216-21.
16. Benitez-Rosario MA, Ferla M, Salinas-Martin A, Martinez-Castillo LP, Martin-Ortega JJ. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain. Cancer 2004;101:2866-73.
17. Mercadante S, Ferrera P, Villari P, Casuccio A. Rapid switching between transdermal fentanyl and methadone in cancer patients. J Clin Oncol 2005;23:5229-34.
18. Benitez-Rosario MA, Salinas-Martin A, Aguirre-Jaime A, Perez-Mendez L, Feria M. Morphine-methadone opioid rotation in cancer patients: Analysis of dose ratio predicting factors. J Pain Symptom Manage 2009;37:1061-8.
19. Mercadante S, Arcuri E. Hyperalgesia and opioid switching. Am J Hosp Palliat Care 2005;22:291-4.
20. Mercadante S, Casuccio A, Fulfaro F, etal. Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: A prospective studies. J Clin Oncol 2001;19:2898-904.
21. Bunten H, Liang WJ, Pounder DJ, Seneviratne C, Osselton D. OPRM1 and CYP2B6 gene variants as risk factors in methadone-related deaths. Clin Pharmacol Ther 2010;88:383-9.
22. Klepstad P, Fladvad T, Skorpen F, etal. Influence from genetic variability on opioid use for cancer pain: A European genetic association study of 2, 294 cancer pain patients. Pain 2011;152:1139-45.